These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8181502)

  • 1. Guillain-Barré syndrome associated with IgM anti-GM1 antibody following Campylobacter jejuni enteritis.
    Sugita K; Ishii M; Takanashi J; Niimi H; Yuki N
    Eur J Pediatr; 1994 Mar; 153(3):181-3. PubMed ID: 8181502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis.
    Yuki N; Yoshino H; Sato S; Miyatake T
    Neurology; 1990 Dec; 40(12):1900-2. PubMed ID: 2247243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni enteritis].
    Tsuda N; Negoro K; Morimatsu M; Saito K; Yuki N
    Rinsho Shinkeigaku; 1995 Feb; 35(2):208-10. PubMed ID: 7781242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
    Tang J; Yuan J; Hao H
    Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
    Koga M; Yuki N; Takahashi M; Saito K; Hirata K
    J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis.
    Koga M; Yuki N; Hirata K
    J Neuroimmunol; 1999 May; 96(2):245-50. PubMed ID: 10337924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A patient with Guillain-Barré syndrome in association with Campylobacter jejuni enteritis (PEN19:LIO7) in a patient with HLA-B52 antigen].
    Kaida K; Yuki N; Takahashi M; Kamakura K; Nagata N
    Rinsho Shinkeigaku; 1994 Jul; 34(7):733-5. PubMed ID: 7955736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
    Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
    Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.
    Hao Q; Saida T; Kuroki S; Nishimura M; Nukina M; Obayashi H; Saida K
    J Neuroimmunol; 1998 Jan; 81(1-2):116-26. PubMed ID: 9521613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré syndrome and Fisher's syndrome following Campylobacter jejuni infection.
    Yuki N; Miyatake T
    Ann N Y Acad Sci; 1998 Jun; 845():330-40. PubMed ID: 9668366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection.
    Rees JH; Gregson NA; Hughes RA
    Ann Neurol; 1995 Nov; 38(5):809-16. PubMed ID: 7486873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulminant Guillain-Barré syndrome after Campylobacter jejuni enteritis and monospecific anti-GT1a IgG antibody.
    Okuda B; Koga M; Katsuta T; Okamoto K; Yuki N
    Intern Med; 2002 Oct; 41(10):889-91. PubMed ID: 12413017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
    Yuki N
    Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
    Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
    Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoadsorption therapy in Guillain-Barré syndrome.
    Hirai K; Kihara M; Nakajima F; Miyanomae Y; Yoshioka H
    Pediatr Neurol; 1998 Jul; 19(1):55-7. PubMed ID: 9682887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant Guillain-Barrè syndrome after Campylobacter jejuni enteritis and anti-ganglioside antibody.
    Saito T
    Intern Med; 2002 Oct; 41(10):760-1. PubMed ID: 12412991
    [No Abstract]   [Full Text] [Related]  

  • 17. [Guillain-Barré syndrome of axonal type, Campylobacter jejuni infection and anti-ganglioside GM1 antibodies].
    Attarian S; Bonnefoi-Kyriacou B; Gayraud D; Mignard P; Boucraut J; Pouget J; Viallet F
    Rev Neurol (Paris); 1997 Apr; 153(3):205-8. PubMed ID: 9296136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity of anti-GM1 antibodies in Guillain-Barré syndrome patients.
    Deisenhammer F; Keir G; Pfausler B; Thompson EJ
    J Neuroimmunol; 1996 May; 66(1-2):85-93. PubMed ID: 8964918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guillain-barré syndrome associated Campylobacter jejuni serotype Penner 2: a case report].
    Watanabe M; Kinoshita I; Hujimoto M; Nakane S; Motomura M; Nakamura T; Kusunoki S; Takahashi M; Saitoh K
    No To Shinkei; 2001 Aug; 53(8):759-62. PubMed ID: 11577419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical correlates of high-titer IgG anti-GM1 antibodies.
    Kornberg AJ; Pestronk A; Bieser K; Ho TW; McKhann GM; Wu HS; Jiang Z
    Ann Neurol; 1994 Feb; 35(2):234-7. PubMed ID: 8109905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.